| Literature DB >> 29552106 |
Yuanshan Yao1, Haibo Shen1, Yinjie Zhou1, Zhenhua Yang1, Hongbo Huang1.
Abstract
The aim of this study was to investigate the feasibility and safety of thoracoscopic surgery in the treatment of lung cancer and its effect on serum D-dimer. A total of 218 patients with lung cancer treated in the Department of Thoracic Surgery of Ningbo No. 2 Hospital from January 1, 2013 to December 31, 2016, were retrospectively analyzed. Of the 218 patients, 120 patients underwent thoracotomy (thoracotomy group) and 98 patients underwent thoracoscopic surgery (thoracoscopy group). The clinical efficacy in the perioperative period and serum D-dimer level were compared between the two groups. In the present study, the intraoperative blood loss, blood transfusion rate, postoperative hospital stay, thoracic drainage time and volume in the thoracoscopy group were significantly shorter or smaller than those in the thoracotomy group (P<0.05), but there was no statistically significant difference in the average operation time between the thoracoscopy and the thoracotomy group. The incidence rate from moderate to severe pains in incisions after operation, the use rate of analgesics and the average disappearance time of the pain in incisions in the thoracoscopy were lower than those in the thoracotomy group (P<0.05). The amount of serum D-dimer immediately after operation in the thoracotomy group was significantly increased compared with that before operation (P<0.05), but there was no significant increase in the thoracoscopy group. At 24 h after operation, the serum D-dimer level in the two groups was further increased (P<0.05), and the comparison between the two groups showed that the levels of serum D-dimer in the thoracoscopy group immediately and at 24 h after operation were significantly lower than those in the thoracotomy group (P<0.05). The incidence rate of postoperative complications in the thoracoscopy was lower than that in the thoracotomy group, but the difference was not statistically significant. Our results show that thoracoscopic surgery is feasible and safe in the treatment of lung cancer. Compared with the thoracotomy group, the intraoperative condition and postoperative recovery have obvious advantages. The postoperative blood of patients is hypercoagulable and D-dimer increased gradually after 24 h. The effect of thoracoscopic surgery on serum D-dimer is relatively less effective.Entities:
Keywords: clinical efficacy; lung cancer; perioperative period; serum D-dimer; thoracoscopy
Year: 2018 PMID: 29552106 PMCID: PMC5840647 DOI: 10.3892/ol.2018.7839
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Figure 1.Immunohistochemical images for: (A) Lung squamous cell carcinoma, (B) adenocarcinoma, and (C) small cell carcinoma.
Comparisons of clinical data of patients between the thoracotomy and the thoracoscopy groups.
| General data | Thoracotomy group (n=120) | Thoracoscopy group (n=98) | χ2/t/Z | P-value |
|---|---|---|---|---|
| Age (years) | 55.63±8.01 | 56.04±6.92 | 0.792 | 0.473 |
| Sex | ||||
| M/F | 68/52 | 52/46 | 0.280 | 0.590 |
| Clinical symptoms, n (%) | ||||
| Cough | 53 (44.17) | 45 (45.92) | 0.067 | 0.796 |
| Expectoration | 20 (16.67) | 10 (10.20) | 2.730 | 0.099 |
| Hemoptysis | 32 (26.67) | 24 (24.49) | 0.134 | 0.714 |
| Chest distress | 12 (10.00) | 7 (7.14) | 0.554 | 0.457 |
| Emaciation | 33 (27.50) | 28 (28.57) | 0.031 | 0.861 |
| Pyrexia | 17 (14.17) | 11 (11.22) | 0.417 | 0.518 |
| No symptom | 20 (16.67) | 16 (16.33) | 0.005 | 0.946 |
| Past history, n (%) | ||||
| Smoking | 82 (68.33) | 60 (61.22) | 1.200 | 0.273 |
| Hypertension | 23 (19.17) | 16 (16.33) | 0.296 | 0.586 |
| Diabetes | 32 (26.67) | 21 (21.43) | 0.804 | 0.370 |
| COPD | 34 (28.33) | 19 (19.39) | 2.346 | 0.126 |
| The ASA grading, n (%) | ||||
| Grade I | 42 (35.00) | 45 (45.92) | ||
| Grade II | 65 (54.17) | 45 (45.92) | ||
| Grade III | 13 (10.83) | 8 (8.16) | ||
| Maximum diameter of lesion (cm) | 2.81±0.32 | 3.05±0.50 | 0.469 | 0.674 |
| Lesion site, n (%) | −0.723 | 0.470 | ||
| Left upper lobe | 28 (23.33) | 25 (25.51) | ||
| Left lower lobe | 16 (13.33) | 15 (15.31) | ||
| Right upper lobe | 28 (23.33) | 23 (23.47) | ||
| Right middle lobe | 12 (10.00) | 10 (10.20) | ||
| Right lower lobe | 36 (30.00) | 25 (25.51) | ||
| Pathological type, n (%) | −1.903 | 0.057 | ||
| Squamous carcinoma | 39 (32.50) | 42 (42.86) | ||
| Adenocarcinoma | 46 (38.33) | 38 (38.78) | ||
| Adeno-squamous carcinoma | 18 (15.00) | 10 (10.20) | ||
| Others | 17 (14.17) | 8 (8.16) | ||
| Pathological stage, n (%) | −0.444 | 0.657 | ||
| IA | 35 (29.17) | 31 (31.63) | ||
| IB | 42 (35.00) | 35 (35.71) | ||
| IIA | 16 (13.33) | 12 (12.24) | ||
| IIB | 17 (14.17) | 10 (10.20) | ||
| IIIA | 9 (7.50) | 10 (10.20) | ||
| IIIB | 1 (0.83) | 0 | ||
| Serum D-dimer (mg/l) | 0.37±0.16 | 0.36±0.15 | −0.148 | 0.882 |
M/F, male/female; COPD, chronic obstructive pulmonary disease; ASA, American Society of Anesthesiologists.
Comparison of intraoperative condition of patients between the thoracotomy and thoracoscopy groups.
| Intraoperative condition | Thoracotomy group (n=120) | Thoracoscopy group (n=98) | χ2/t | P-value |
|---|---|---|---|---|
| Operative time (min) | 126.17±39.23 | 132.23±32.56 | 1.106 | 0.276 |
| Intraoperative blood loss (ml) | 234.23±53.72 | 110.64±18.25 | −6.316 | <0.001 |
| Blood transfusion n (%) | 27 (22.50) | 8 (8.16) | 8.227 | 0.004 |
Comparison of postoperative recovery condition of patients between the thoracotomy and thoracoscopy groups.
| Postoperative condition | Thoracotomy group (n=120) | Thoracoscopy group (n=98) | χ2/t | P-value |
|---|---|---|---|---|
| Thoracic drainage time (days) | 6.27±2.13 | 4.38±1.92 | −5.670 | <0.001 |
| Thoracic drainage volume (ml) | 1453.57±611.25 | 1024.78±556.95 | −5.743 | <0.001 |
| Postoperative hospital stay (days) | 13.84±2.31 | 10.12±2.56 | −5.694 | <0.001 |
| Incidence rate of moderate to severe pains in incisions at 6 h after operation, n (%) | 72 (60.00) | 20 (20.41) | 34.667 | <0.001 |
| Use rate of analgesics, n (%) | 68 (56.67) | 18 (18.37) | 33.126 | <0.001 |
| Average time of the disappearance of pain in incisions (h) | 72.58±20.98 | 28.67±14.37 | −53.642 | <0.001 |
Comparison of changes in serum D-dimer of patients after operation between the thoracotomy and thoracoscopy groups (mg/l).
| Serum D-dimer | Thoracotomy group (n=120) | Thoracoscopy group (n=98) | t | P-value |
|---|---|---|---|---|
| Before operation | 0.37±0.16 | 0.36±0.15 | −0.148 | 0.882 |
| Immediately after operation | 0.55±0.26 | 0.42±0.19 | 4.001 | <0.001 |
| At 24 h after operation | 0.93±0.17 | 0.68±0.23 | 8.585 | <0.001 |
| F-value | 277.785 | 67.492 | ||
| P-value | <0.001 | <0.001 | ||
| P1:2 | <0.001 | 0.132 | ||
| P1:3 | <0.001 | <0.001 | ||
| P2:3 | <0.001 | <0.001 |
Figure 2.Comparison of serum D-dimer level of patients after operation between the thoracotomy and thoracoscopy groups. The D-dimer content of the two groups is gradually increased with the increase of time, and D-dimer content in the thoracoscopy group is lower than that in the thoracotomy group at the same time point.
The changes of blood coagulation indexes before and after operation of the two groups (mean ± SD).
| Groups | Time | PT (sec) | APTT (sec) | TT (sec) | Coagulation factor V(g/l) | Coagulation factor VII(g/l) |
|---|---|---|---|---|---|---|
| Thoracoscopy | Before surgery | 12.32±0.87 | 28.65±2.65 | 17.32±2.34 | 2.19±0.43 | 2.19±0.43 |
| After surgery | 12.88±0.88 | 31.22±2.12 | 18.32±3.02 | 1.81±0.32[ | 1.81±0.32[ | |
| Thoracotomy | Before surgery | 12.45±0.98 | 28.98±2.01 | 17.43±2.19 | 2.23±0.52 | 2.23±0.52 |
| After surgery | 12.78±0.97 | 32.43±1.35 | 18.97±3.21 | 1.82±0.54[ | 1.82±0.54[ |
Compared with that before surgery
P<0.05; SD, standard deviation; PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time.
Comparison of condition of postoperative complications of patients between the thoracotomy and thoracoscopy groups [n (%)].
| Complication | Thoracotomy group (n=120) | Thoracoscopy group (n=98) | χ2 | P-value |
|---|---|---|---|---|
| Arrhythmia | 17 (14.17) | 11 (11.22) | 0.417 | 0.518 |
| Atrial fibrillation | 10 (8.33) | 6 (6.12) | 0.388 | 0.533 |
| Supraventricular tachycardia | 4 (3.33) | 5 (5.10) | 0.055 | 0.815 |
| Ventricular premature beat | 1 (0.83) | 0 | 0.000 | 1.000 |
| Ventricular fibrillation | 0 | 0 | 0.000 | 1.000 |
| Sinus bradycardia | 2 (1.67) | 0 | 0.325 | 0.569 |
| Lung | ||||
| Atelectasis | 1 (0.83) | 2 (2.04) | 0.031 | 0.860 |
| Pulmonary infection | 26 (21.67) | 20 (20.41) | 0.051 | 0.821 |
| Pulmonary air leak after operation | 2 (1.67) | 2 (2.04) | 0.000 | 1.000 |
| Empyema | 2 (1.67) | 1 (1.02) | 0.000 | 1.000 |
| Chylothorax | 1 (0.83) | 0 | 0.000 | 1.000 |
| Thoracic hemorrhage | 0 | 1 (1.02) | 0.000 | 1.000 |
| Incision infection | 10 (8.33) | 2 (2.04) | 4.106 | 0.043 |
| Deep venous thrombosis | 3 (2.50) | 0 | 0.984 | 0.321 |
| Total | 62 (51.67) | 39 (39.80) | 3.057 | 0.080 |